Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 248-383-5 | CAS number: 27277-00-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Carcinogenicity
Administrative data
Description of key information
Oral: discriminating dose = approximately 5 mg/kg bw /day, male/female, mice, pre-guideline study, Leonard 1977
Key value for chemical safety assessment
Carcinogenicity: via oral route
Link to relevant study records
- Endpoint:
- carcinogenicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Non-GLP, available as unpublished report, minor restrictions in design and/or reporting but otherwise adequate for assessment.
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- 25 mice per sex/dose were daily exposed to 0, 5, and 20 ppm test substance via diet for a duration of 78 weeks. The tumour incidence was investigated.
- GLP compliance:
- no
- Species:
- mouse
- Strain:
- not specified
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Mean body weight measured in week 1 of the study: Control group, 27.16 g males and 21.40 g females; 5 ppm dose group, 23.60 g males and 21.96 g females; 20 ppm dose group, 27.84 g males and 24.96 g females
- Age at study initiation: Approx. 2 months
- Housing: 6 or 7 per cage, wire mesh cages (26 cm x 26 cm x 9.5)
- Diet: Pelleted powder 'O' containing: 26.34 % barley, 9.10 % maize meal, 18.30 % sussex ground oats, 18.08 % bran, 4.46 % white fish meal, 1.34 % yeast, 13.17 % dried skimmed milk powder, 8.71 % meat and bone meal, 0.45 % salt, and 0.04 % 'nuclo' vitamine mixture (A, D3 and B2), ad libitum.
- Water: ad libitum
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 2
- Humidity (%): approximately 50%
- Photoperiod (hrs dark / hrs light): 12/12 - Route of administration:
- oral: feed
- Vehicle:
- other: Maize oil and malt extract
- Details on exposure:
- DIET PREPARATION
Diets were prepared in a 'Hobart' mixer using powder 'O' diet. The appropriate concentration of the test substance was added to the dry powder 'O' and mixed for ten minutes prior to the addition of the following ingredients: 4 kg powder 'O', 900 g malt extract, 100 mL maize oil. Water was added as required to obtain the correct consistency for pelleting by mincing machine, and the diet was then dried under electric wall heaters. - Analytical verification of doses or concentrations:
- not specified
- Duration of treatment / exposure:
- 78 weeks
- Frequency of treatment:
- daily
- Remarks:
- Doses / Concentrations:
0, 5 and 20 ppm
Basis:
nominal in diet - Remarks:
- Doses / Concentrations:
0, 1.25, and 5 mg/kg/day
Basis:
other: estimated intake - No. of animals per sex per dose:
- 25
- Control animals:
- yes, plain diet
- Details on study design:
- An additional five male and five female mice were dosed in parallel with each group for blood level estimations after one month duration. However only two male and two female animals were used from dose group 5 and 20 ppm. The remaining animals continued on the trial and the survivors were killed without necropsy (apart from 1 animal) at termination.
- Observations and examinations performed and frequency:
- CAGE SIDE OBSERVATIONS: Yes
BODY WEIGHT: Yes
Time schedule for examinations: weekly
FOOD CONSUMPTION AND COMPOUND INTAKE:
Food consumption was measured during the first week of dosing on all animals for seven days.
CLINICAL CHEMISTRY: Yes
Two male and two female mice from the 5 and 20 ppm dose groups which had medicated diet in parallel with the main test animals, were bled 45 days after dosing commenced. Serum concentrations of the test substance were determined. - Sacrifice and pathology:
- GROSS PATHOLOGY: Yes
With the exception of four mice from the control group, 4 mice from the 5 ppm dose group and two mice from the 20 ppm dose group, all animals were necropsied after euthanasia with coal gas.
HISTOPATHOLOGY: Yes
After macroscopic examination, samples of tissues were taken for microscopic examination. The following organs were placed in Zenker's 1994 fixative and stained with haematoxylin and eosin: Accessory sex organs (left epididymis, seminal vesicle and uterus), adrenal (L), bladder (urinary), gonad (left ovary or testis), heart, intestine (large and small), kidney (L), liver, lung, lymph node (abdominal), mammary gland, muscle, pancreas, spleen, stomach, thyroid, thymus, and any other abnormal tissues. - Statistics:
- Body weight: Student's t-test
- Details on results:
- CLINICAL SIGNS AND MORTALITY
The animals were generally in good body condition. The male mice had a tendency to fight and due to lacerations, occasionally this resulted in the formation of abscesses. Several mice suffered from minor respiratory problems. One mouse from the 5 ppm dose group was destroyed with middle ear disease. After ten months, two mice from the 20 ppm dose group convulsed on the same day whilst being weighed. This occurred again six weeks later with one of the animals. Other observations reported were thought to be associated with the development of tumours. See any other information on results incl. tables for the mortality rate.
BODY WEIGHT AND WEIGHT GAIN
There was a statistically significant lowered body weight in both sexes at termination of the test and this appeared to be dose related. See any other information on results incl. tables for the statistical analysis of body weight.
FOOD CONSUMPTION AND COMPOUND INTAKE
The mean daily food consumption per mouse was as follows: Control group: males 5.3 g and females 3.9 g; 5 ppm dose group: males 4.9 g and females 3.7 g; 20 ppm dose group: males 4.9 g and females 4.5 g.
CLINICAL CHEMISTRY
Serum concentration of the test substance were determined for two males and two females in both dose groups. 5 ppm resulted in serum concentrations of 0.0144 and 0.0117 µg/mL in males and 0.0055 and 0.0096 µg/mL in females. 20 ppm resulted in serum concentrations of 0.0274 and 0.0110 µg/mL in males and 0.0089 and 0.0082 µg/mL in females.
PATHOLOGY
There were no consistent microscopic and macroscopic findings observed in the treated or control groups. See any other information on results incl. tables for the incidence of tumours. - Relevance of carcinogenic effects / potential:
- No biologically significant difference between the control and treated mice.
- Dose descriptor:
- NOAEC
- Effect level:
- > 5 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: The total incidence of tumours in the highest dose group and incidence in particular organ systems showed no biologically significant difference between the control and treated mice.
- Conclusions:
- The total incidence of tumours in the highest dose group and incidence in particular organ systems showed no biologically significant difference between the control and treated mice.
- Executive summary:
25 mice per sex/dose were daily exposed to 0, 5, and 20 ppm (approximately 1.25 and 5 mg/kg bw/day) test substance via diet for a duration of 78 weeks. Food consumption was measured during the first week of dosing for seven days. The mean daily food consumption per mouse was as follows: control group: males 5.3 g and females 3.9 g, 5 ppm dose group: males 4.9 g and females 3.7 g, 20 ppm dose group: males 4.9 g and females 4.5 g. Serum concentration of the test substance were determined for two males and two females in both dose groups. 5 ppm resulted in serum concentrations of 0.0144 and 0.0117 µg/mL in males and 0.0055 and 0.0096 µg/mL in females. 20 ppm resulted in serum concentrations of 0.0274 and 0.0110 µg/mL in males and 0.0089 and 0.0082 µg/mL in females. There was a statistically significant lowered body weight in both sexes at termination of the test and this appeared to be dose related. The total incidence of tumours in the highest dose group and incidence in particular organ systems showed no biologically significant difference between the control and treated mice.
Reference
Mortality rate
|
Time of death (months) |
||||
group |
sex |
0 - 6 |
7 - 12 |
13 - 18 |
Survived to end |
Control diet |
Male |
1 |
2 (2) |
4 (2) |
18 |
|
Female |
0 |
0 |
5 |
20 |
5 ppm |
Male |
0 |
2 (2) |
7 (1) |
16 |
|
Female |
0 |
1 |
3 (1) |
21 |
20 ppm |
Male |
2 |
1 |
5 |
17 |
|
Female |
1 (1) |
2 |
5 (1) |
17 |
( ) = no necropsy
Mortality was slightly higher in the high dose group.
Statistical analysis of body weight (g)
Sex |
Group I |
Group II |
Group III |
|||||
No. |
Mean |
No. |
Mean |
P |
No. |
Mean |
P |
|
Male |
18 |
58.4 |
16 |
55.8 |
NS |
17 |
47.6 |
<0.001 |
Female |
20 |
51.9 |
21 |
46.8 |
NS |
17 |
42.8 |
<0.01 |
P = Probability (students ‘t’ test) compared with control mean.
NS = Not significant.
Incidence of tumours
Organ |
males |
|
||||
|
control |
5 ppm |
20 ppm |
control |
5 ppm |
20 ppm |
No. examined |
21/25 |
22/25 |
25/25 |
25/25 |
24/25 |
23/25 |
Bladder |
0 |
0 |
0 |
0 |
0 |
1 |
Bone marrow |
1 |
2 |
1 |
1 |
0 |
1 |
Liver |
6 |
7 |
5 |
2 |
2 |
2 |
Lung |
0 |
0 |
2 |
2 |
2 |
0 |
Lymph node |
0 |
1 |
0 |
0 |
0 |
0 |
Mammary gland |
0 |
0 |
0 |
0 |
1 |
0 |
Pancreas |
0 |
0 |
0 |
0 |
1 |
0 |
Spleen |
0 |
0 |
3 |
0 |
3 |
1 |
Testes |
1 |
0 |
0 |
0 |
0 |
0 |
Thymus |
1 |
0 |
0 |
1 |
1 |
1 |
Uterus |
0 |
0 |
0 |
1 |
0 |
0 |
Vagina |
0 |
0 |
0 |
1 |
0 |
0 |
Total |
9 |
10 |
11 |
8 |
10 |
6 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 5 mg/kg bw/day
- Study duration:
- subchronic
- Species:
- mouse
- Quality of whole database:
- non-GLP compliant pre-guideline study, klimisch 2
Carcinogenicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Carcinogenicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Based on the results of a 78 week mice carcinogenicity study the test substance is not classified according to the EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No. 1272/2008.
Additional information
25 mice per sex/dose were daily exposed to 0, 5, and 20 ppm (approximately 1.25 and 5 mg/kg bw/day) test substance via diet for a duration of 78 weeks. Food consumption was measured during the first week of dosing for seven days. The mean daily food consumption per mouse was as follows: control group: males 5.3 g and females 3.9 g, 5 ppm dose group: males 4.9 g and females 3.7 g, 20 ppm dose group: males 4.9 g and females 4.5 g. Serum concentration of the test substance were determined for two males and two females in both dose groups. 5 ppm resulted in serum concentrations of 0.0144 and 0.0117 µg/mL in males and 0.0055 and 0.0096 µg/mL in females. 20 ppm resulted in serum concentrations of 0.0274 and 0.0110 µg/mL in males and 0.0089 and 0.0082 µg/mL in females. There was a statistically significant lowered body weight in both sexes at termination of the test and this appeared to be dose related. The total incidence of tumours in the highest dose group and incidence in particular organ systems showed no biologically significant difference between the control and treated mice (Leonard,1977).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.